Adrian Kimber is the Chief Commercial Officer at Fractyl Health.
Adrian has excelled at bringing innovative therapies to market, crafting compelling value propositions, devising effective go-to-market strategies, assembling high-performing commercial teams, and implementing robust systems and processes for the global introduction of biotechnology and medical device companies.
In his previous role as Global VP & Commercial Head at Biotronik Neuro, Adrian spearheaded the introduction of daily remote monitoring for patients with spinal cord stimulation devices, from inception to FDA approval and successful commercialization in the United States.
Prior to joining Fractyl Health, Adrian held progressively senior commercial roles at prominent companies such as Biotronik, Abbott, Olympus, and Medtronic, across the United Kingdom, Australia, and the United States. He earned his BSc in Sports Science from London Metropolitan University.
